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Abstract
5-HT1A receptors couple to diﬀerent Go/Gi proteins in order to mediate a wide range of physiological
actions. While activation of post-synaptic 5-HT1A receptors is mainly related to inhibition of adenylyl
cyclase activity, functionality of autoreceptors located in raphe nuclei has been classically ascribed to
modiﬁcations of the activity of potassium and calcium channels. In order to evaluate the possible existence
of agonist-directed traﬃcking for 5-HT1A autoreceptors in the rat dorsal raphe nucleus, we studied their
activation by two agonists with a diﬀerent proﬁle of eﬃcacy [(+)8-OH-DPAT and buspirone], addressing
simultaneously the identiﬁcation of the speciﬁc Ga subtypes ([35S]GTPcS labelling and immunoprecipi-
tation) involved and the subsequent changes in cAMP formation. A signiﬁcant increase (32%, p<0.05)
in (+)8-OH-DPAT-induced [35S]GTPcS labelling of immunoprecipitates was obtained with anti-Gai3
antibodies but not with anti-Gao, anti-Gai1, anti-Gai2, anti-Gaz or anti-Gas antibodies. In contrast, in the
presence of buspirone, signiﬁcant [35S]GTPcS labelling of immunoprecipitates was obtained with anti-Gai3
(50%, p<0.01), anti-Gao (32%, p<0.01) and anti-Gai2 (29%, p<0.05) antibodies, without any labelling
with anti-Gai1, anti-Gaz or anti-Gas. The selective 5-HT1A antagonist WAY 100635 blocked the labelling
induced by both agonists. Furthermore, (+)8-OH-DPAT failed to modify forskolin-stimulated cAMP
accumulation, while buspirone induced a dose-dependent, WAY 100635-sensitive, inhibition of this
response (Imax 30.8¡4.9, pIC50 5.95¡0.46). These results demonstrate the existence of an agonist-
dependency pattern of G-protein coupling and transduction for 5-HT1A autoreceptors in native brain
tissue. These data also open new perspectives for the understanding of the diﬀerential proﬁles of agonist
eﬃcacy in pre- vs. post-synaptic 5-HT1A receptor-associated responses.
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Introduction
The neurotransmitter serotonin (5-HT) exerts its
actions through the activation of at least 14 diﬀerent
receptor subtypes, from 5-HT1 to 5-HT7 (Hoyer et al.
2002). Substantial data exist to support a link between
the serotonergic system and the physiopathology of
neuropsychiatry diseases. In this regard, 5-HT1A recep-
tors, present in high concentrations in the central
nervous system, appear to be of special relevance:
adaptive changes in the functionality of this subtype
are believed to underline the therapeutic eﬀective-
ness of anxiolytic and antidepressant drugs (Blier &
Ward, 2003; Hensler, 2003). 5-HT1A receptors are
present in high densities in limbic brain areas (hippo-
campus, lateral septum), cortical areas (particularly
prefrontal and entorhinal cortex), as well as in the
raphe nuclei, both dorsal raphe nucleus (DRN) and
median raphe nucleus (MRN) (Pazos & Palacios, 1985 ;
Pompeiano et al. 1992). While those receptors in limbic
and cortical areas are post-synaptically localized,
5-HT1A receptors in raphe nuclei are localized in cell
bodies and dendrites, where they act as autoreceptors
(Sotelo et al. 1990). 5-HT1A receptors are coupled to the
Gi/o family of G proteins, which include pertussis
toxin-sensitive Gi1, Gi2, Gi3 and Go, and pertussis toxin-
insensitive Gz proteins (reviewed in Raymond et al.
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1999). In heterologous recombinant systems, 5-HT1A
receptors preferentially interact with Gai3 subunits,
and, to a less extent, with other members of the group:
Gai2<Gao<Gai1<Gaz (Bertin et al. 1992 ; Fargin
et al. 1991 ; Garnovskaya et al. 1997 ; Liu et al. 1994;
Newman-Tancredi et al. 2002). Interaction of 5-HT1A
receptors with Gaq and Gas is very weak (Raymond
et al. 1993). In rat brain tissue, a regional pattern of
preferential coupling to Ga subunits has been re-
ported for this receptor (Mannoury la Cour et al. 2006).
On the basis of agonist-directed traﬃcking of recep-
tor signalling theory (Kenakin, 1995), it is now widely
accepted that, depending on the nature of the agonist,
receptor stimulation will selectively activate one speci-
ﬁc G-protein subtype and downstream transduction
pathway (Kenakin, 1995 ; Newman-Tancredi et al.
1997). Coupling of 5-HT1A receptors to Gi/Go proteins
leads to the mediation of a range of actions that in-
clude inhibition of adenylyl cyclase (AC), opening of
K+ channels, closing of Ca2+ channels, and stimu-
lation of phospholipase Cb and mitogen-activated
protein kinase (MAPK) (Raymond et al. 2001).
5-HT1A autoreceptors localized over raphe nuclei
play a critical role in the regulation of the functionality
of 5-HT neurotransmission : in the rat DRN, activation
of 5-HT1A receptors results in the inhibition of neuro-
nal cell ﬁring (Sprouse & Aghajanian, 1987). Modu-
lation of these autoreceptors is therefore of high
relevance in the mechanism of action of 5-HT-acting
drugs, including antidepressants and antipsychotics.
Hyperpolarization through opening of potassium
channels (Blier et al. 1993 ; Innis & Aghajanian, 1987;
Penington &Kelly, 1990 ; Sprouse &Aghajanian, 1987),
as well as inhibition of voltage-dependent calcium
currents (Chen & Penington, 1996 ; Penington & Kelly,
1990) have been identiﬁed as post-receptor mech-
anisms linked to the activation of 5-HT1A receptors in
rat DRN; however, no inhibition of AC activity has
been reported following activation with agonists such
as (+)-8-OH-DPAT (Clarke et al. 1996 ; Johnson et al.
1997) or 5-CT (Clarke et al. 1996). Interestingly, some
experimental evidences for functional selectivity re-
garding 5-HT1A receptors have been recently pub-
lished (Newman-Tancredi et al. 2009).
It is noteworthy that the pharmacological proﬁle of
diﬀerent 5-HT1A-acting drugs depends on the synaptic
localization of the receptor : while several compounds,
i.e. (+)8-OH-DPAT, show a high level of eﬃcacy re-
gardless the pre- or post-synaptic localization, behav-
ing as full agonists, other drugs, such as buspirone,
show a complex proﬁle : low eﬃcacy at post-synaptic
receptors (partial agonist), but signiﬁcantly higher
eﬃcacy at 5-HT1A receptors in raphe nuclei (Sussman,
1998). Although this diﬀerence has been classically
explained in terms of spare receptors (Meller et al.
1990), the possibility exists that it is really reﬂecting a
case of functional selectivity.
In order to evaluate the existence of agonist depen-
dence in 5-HT1A receptor activation of speciﬁc sub-
types of Ga proteins and downstream transduction
pathway at the level of rat DRN, we have analysed the
activation of this receptor by two agonists with diﬀer-
ent proﬁles of eﬃcacy: (+)8-OH-DPAT (full agonist)
and buspirone (partial agonist), studying the subtype
of Ga coupled (immunoprecipitation of [35S]GTPcS
labelled Ga subunits) and comparing it with their
eﬀects on cAMP inhibition.
Material and methods
Animals
Male Wistar rats weighing 200–250 g were group-
housed andmaintained on 12 h light/dark cycle (lights
on 08:00 hours), with access to food and water avail-
able ad libitum. All experimental procedures were
performed according to Spanish legislation and the
European Communities Council Directive on ‘Protec-
tion of Animals Used in Experimental and Other
Scientiﬁc Purposes’ (86/609/EEC) in accordance with
the Declaration of Helsinki.
Reagents
[35S]GTPcS (1250 Ci/mmol) was purchased from
DuPont NEN (Brussels, Belgium). D,L-dithiothreitol
(DTT), guanosine 5k-diphosphate sodium salt (GDP),
guanosine 5k-triphosphate sodium salt hydrate (GTP),
guanosine-5-O-(3-thio)triphosphate (GTPcS), adeno-
sine 5k-triphosphate disodium salt (ATP), ethylene-
diaminetetraacetic acid (EDTA), ethylene glycol-bis
(b-aminoethyl ether)-N,N,Nk,Nk-tetraacetic acid tetra-
sodium salt (EGTA), leupeptin, 3-isobutylmethyl-
xanthine (IBMX), phosphocreatine, creatine
phosphokinase myokinase, forskolin, Chaps, phenyl-
methylsulfonylﬂuoride ; aprotinin, leupetin, pestatin,
antipain, chimostatin, sodium deoxicholate, igepal,
(+)8-hydroxy-2-di-n-propylamino-tetralin [(+)8-OH-
DPAT] and [N-[2-(4-(2-methoxyphenyl)-1-piperazinyl]
ethyl]-N-2-pyridinyl-cyclohexanecarboxamide)-maleate
(WAY 100635) were obtained from Sigma-Aldrich
(USA). Buspirone were obtained from RBI (Spain). SB
269970 was from Tocris Cookson Ltd (UK). All other
chemicals used were analytical grade. Rabbit anti-Gai1
(sc-391), anti-Gai2 (sc-7276), anti-Gai3 (sc-262), anti-
Gaiz (sc-388) and anti-Gao (sc-387) were purchased
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from Santa Cruz Biotechnology Inc. (Germany), GB-
Sepharose beads were from GE Healthcare Ltd (UK).
Tissue preparation
Rats were killed by decapitation. Their brains were
quickly removed and the dorsal raphe area was care-
fully dissected at cold temperature (0–4 xC) by a series
of steps as previously reported (Echizen & Freed,
1983) and stored at x80 xC until required. For auto-
radiography experiments, coronal sections of 20 mm
thickness were cut atx20 xC using a microtome cryo-
stat (Microm HM550, Germany) and thaw-mounted in
gelatinized slides and stored atx20 xC until required.
[35S]GTPcS autoradiography
Labelling of brain sections with [35S]GTPcS was per-
formed as described previously (Castro et al. 2003).
Slide-mounted sections were preincubated for 30 min
at room temperature in a buﬀer containing 50 mM
Tris–HCl, 0.2 mM EGTA, 3 mM MgCl2, 100 mM NaCl,
1 mM DTT and 2 mM GDP (pH 7.7). Slides were subse-
quently incubated, for 2 h, in the same buﬀer contain-
ing adenosine deaminase (10 mU/ml) with [35S]GTPcS
(0.04 nM) and consecutive sections were co-incubated
with (+)8-OH-DPAT (10x5 M) or buspirone (10x5 M)
alone or in the presence of the selective 5-HT1A antag-
onist WAY 100635 (10x5 M). Non-speciﬁc binding was
determined in the presence of 10 mM GTPcS.
After incubation, the sections were washed twice
for 15 min in cold 50 mM Tris–HCl buﬀer (pH 7.4) at
4 xC, rinsed in distilled cold water and then dried
under a cold air stream. Sections were exposed to
autoradiographic ﬁlm (Biomax MR, Spain) together
with 14C microscales at 4 xC for 2 d.
Membrane preparation
DRN tissues were homogenized using a glass-Teﬂon
driver potter (Heidolph Instruments, GmbH & Co.,
Germany) in ice-cold buﬀer (20 mM Tris–HCl, 1 mM
EGTA, 5 mM EDTA, 300 mM sucrose, 5 mM DTT,
25 mg/ml leupeptin) (pH 7.4) and centrifuged (1500 g)
for 5 min at 4 xC. The supernatants were pelleted
(13000 g) for 15 min and used for AC assay or immuno-
precipitation of [35S]GTPcS-labelled Ga subunits.
Immunoprecipitation of [35S]GTPcS-labelled Ga
subunits
For immunoprecipitation experiments, membranes
from DRN (tissue pooled together from ﬁve rats,
for each speciﬁc Ga protein) were prepared as de-
scribed in the previous section. The ﬁnal pellet was
resupended in assay buﬀer [50 mM Tris–HCl (pH 7.4),
3 mM MgCl2, 1 mM EGTA, 1 mM DTT, 100 mM NaCl,
50 mM GDP]. Then 50 ml of membranes (y250 mg pro-
tein) were incubated in a ﬁnal 100 ml assay volume
with 2 nM [35S]GTPcS and 10x5 M (+)8-OH-DPAT or
buspirone for 30 min at 30 xC. Non-speciﬁc binding
was determined in the presence of 10 mM GTPcS. After
incubation, the membrane suspension was solubilized
for 30 min on ice with 1% Igepal, 0.5% sodium deoxy-
cholate, 0.1% SDS, 2.5 mM Chaps, 0.1 mM phenyl-
methylsulfonylﬂuoride, 0.01 M aprotinin, 1 mg/ml
leupetin, 1 mg/ml pestatin, 1 ml/ml antipain, chimo-
statin. Next, 15 ml of speciﬁc rabbit antibody anti-Gai1,
anti-Gai2, anti-Gai3, anti-Gaz, anti-Gao were incubated
with the solubilized membranes for 45 min at room
temperature, and 100 ml of GB-Sepharose beads were
added and incubated for 3 h at room temperature.
After three washes with 1 ml PBS the Sepharose beads
were pelleted and the entrapped radioactivity was
counted in 4 ml scintillation cocktail in a b counter
(Beckman LS 600 IC, Beckman Instruments Inc., USA).
Antibody speciﬁcity was conﬁrmed in our exper-
imental conditions by Western blot.
AC assay
Fifty microlitres of freshly prepared DRN membranes
(tissue pooled together from ﬁve rats,y50 mg protein)
were incubated for 5 min a 37 xC in 250 ml of 80 mM
Tris–HCl (pH 7.4), 100 mM NaCl, 2 mM MgCl2, 0.2 mM
EGTA, 1 mM EDTA, 60 mM sucrose, 10 mM GTP, 1 mM
DTT, 0.5 mM ascorbic acid, 0.5 mM 3-isobutylmethyl-
xanthine, 5 mM phosphocreatine, 50 U/ml creatine
phosphokinase and 5 U/ml myokinase and either
water (basal AC activity), 5 mM forskolin (forskolin-
stimulated cAMP accumulation), or increased concen-
trations of (+)8-hydroxy-2-di-n-propylamino-tetralin
(+)8-OH-DPAT (10x9x10x4 M) or buspirone (10x8x
10x4 M) in the presence of 5 mM forskolin. The enzy-
matic reaction was started by addition of ATP to a ﬁnal
concentration of 200 mM. The mixture was then incu-
bated (10 min at 37 xC) and the reaction was rapidly
terminated by 5 min incubation at 100 xC. The samples
were centrifuged (13000 g, 5 min) and cAMP accumu-
lation was quantiﬁed in 50 ml supernatant aliquots by
using a [3H]cAMPcommercial kit (TRK432,Amersham
Signal Transduction Assays ; GE Healthcare UK Ltd,
UK). The assays were performed in triplicate.
Protein determination
Membrane protein concentrations were determined
by using the Bio-Rad Protein Assay kit (Bio-Rad,
Germany) using BSA as the standard.
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Data analysis
Autoradiograms were analysed and quantiﬁed using
a computerized image analysis system (Scion Image,
Scion Corporation, USA). For [35S]GTPcS experiments
the data are presented as comparison of percent
stimulation scores vs. basal binding.
Data analysis of agonist individual concentration–
eﬀect curves from cAMP assays were conducted by
nonlinear regression using GraphPad Prism in order
to estimate the theoretical maximal eﬀect (Imax) and
the potency (IC50) of the 5-HT1A agonists. IC50 values
were normalized as –log IC50 (pIC50) for comparison.
Statistical comparison of agonist concentration–
response curves was made using sum of squares F test.
Diﬀerences in the agonist-dependent immunoprecipi-
tation of each G-protein subunit was obtained by using
one-way ANOVA with Newman–Keuls post-hoc tests.
Diﬀerences were taken as statistically signiﬁcant when
p<0.05.
Results
5-HT1A receptor-dependent [
35S]GTPcS binding to
rat brain sections
Basal [35S]GTPcS binding was heterogeneous in rat
brain, with relatively higher levels in DRNwith regard
to other areas such as hippocampus (dentate gyrus
and CA1 ﬁeld) or entorhinal cortex. Basal [35S]GTPcS
binding levels in rat DRN were 597.3¡29.4 (nCi/g
tissue). The co-incubation with the 5-HT1A agonists
(+)8-OH-DPAT (10 mM) and buspirone (10 mM) in-
duced a high stimulation of speciﬁc [35S]GTPcS bind-
ing in DRN [+42.8¡6.9% for (+)8-OH-DPAT and
+26.8¡6.3% for buspirone] (Fig. 1).
In agreement with previous studies, the selective
5-HT1A antagonist WAY 100635 (10 mM) blocked the
eﬀect of (+)8-OH-DPAT and buspirone on stimu-
lation of [35S]GTPcS binding (Fig. 1).
Immunoprecipitation of Ga proteins labelled by
[35S]GTPcS in soluble extracts from (+)8-OH-DPAT-
or buspirone-treated DRN membranes
We used GB-Sepharose beads to bind immunoprecipi-
tates of Ga subunits labelled with [35S]GTPcS from
DRN 5-HT1A receptor/G-protein complexes, after
incubation with either (+)8-OH-DPAT or buspirone
(10 mM) an increase in [35S]GTPcS binding over the
basal value was observed for Gao, Gai2 and Gai3
protein subunits but not for Gai1, Gaz or Gas subunits.
A signiﬁcant (+)8-OH-DPAT-induced [35S]GTPcS
labelling of immunoprecipitates was obtained with
anti-Gai3 (132.0¡5.9%, p<0.05, Student–Newman–
Keuls test after ANOVA) antibody, but not with
anti-Gao, anti-Gai1, anti-Gai2, anti-Gaz or anti-Gas
antibodies (Fig. 2). In contrast, signiﬁcant buspirone-
induced [35S]GTPcS labelling of immunoprecipitates
was obtained with anti-Gai3 (150.0¡3.6%, p<0.01),
anti-Gao (132.0¡3.2%, p<0.01) anti-Gai2 (129.0¡
2.3%, p<0.05) antibodies but not with anti-Gai1,
anti-Gaz or anti-Gas. The selective 5-HT1A antagonist
WAY 100635 (10 mM) blocked both (+)8-OH-DPAT
and buspirone-induced [35S]GTPcS labelling of
G-protein subunits (data not shown).
5-HT1A receptor-mediated inhibition of AC
The selective 5-HT1A agonist (+)8-OH-DPAT (10x9x
10x4 M) failed to signiﬁcantly modify the level of
forskolin-stimulated cAMP accumulation in rat DRN,
although a slight but not signiﬁcant increase was
observed (Emax +10.6¡1.99 ; Fig. 3a). As (+)8-OH-
DPAT also binds to 5-HT7 receptors (coupled to
stimulatory Gs proteins), the possible inﬂuence of this
receptor subtype was also studied. The presence of the
selective 5-HT7 receptor antagonist SB 269970 (10
x5
M)
did not modify the response of cAMP accumulation
(a) (c) (e)
(b) (d) (f)
DRN
Fig. 1. Representative autoradiograms of [35S]GTPcS
binding in coronal sections of rat brain at the midbrain level :
(a) basal binding ; (b) non-speciﬁc binding ; (c) binding
in the presence of (+)8-OH-DPAT (10x5 M) ; (d) binding in
the presence of (+)8-OH-DPAT (10x5 M)+WAY 100635
(10x5 M) ; (e) binding in the presence of buspirone (10x5 M)
and (f) binding in the presence of buspirone (10x5 M)+
WAY 100635 (10x5 M). DRN, Dosal raphe nucleus
(bar, 2 mm).
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to increasing concentrations of (+)8-OH-DPAT in this
rat brain region (Fig. 3a).
In contrast to (+)8-OH-DPAT, buspirone induced
a concentration-dependent decrease in forskolin-
stimulated cAMP accumulation (Fig. 3b) with a maxi-
mum inhibition of 30.8¡4.8% and a pIC50 of 5.95¡
0.46. This buspirone-mediated inhibition of cAMP
accumulation was completely blocked by the 5-HT1A
antagonist WAY 100635 (F=136.9, p<0.001, sum of
squares F test).
Discussion
We here report the existence of selective agonist-
dependent signalling output for 5-HT1A receptors in
the rat DRN, an area of special relevance for 5-HT
neurotransmission, as these receptors regulate the
ﬁring of serotonergic neurons (Sprouse & Aghajanian,
1987). We demonstrate the existence of 5-HT1A
receptor-dependent inhibition of AC activity in this
area, a transductional response which has not been
previously well identiﬁed in the rat. In addition, this
is the ﬁrst demonstration of agonist-directed traﬃck-
ing of 5-HT1A receptors in native rat brain tissue.
Agonist-directed traﬃcking has been previously
suggested in heterologously expressed 5-HT1A recep-
tors (Heusler et al. 2005).
It has been shown that 5-HT1A receptors can physi-
cally couple to multiple distinct Gai proteins in mam-
malian cell membranes. It has also been suggested that
functionality of these receptors inducing AC inhibition
may be mainly mediated by Gai3 and Gai2, and Gai1
(Raymond et al. 1993). Furthermore, the existence
of regional diﬀerences in the coupling of 5-HT1A re-
ceptors to the distinct subtypes of G proteins has been
recently well demonstrated (Mannoury la Cour et al.
2006), under activation with 5-CT, 5-HT1A receptors
interact with Gao and Gai3 in the cerebral cortex,
mainly with Gao in the hippocampus, with Gai3 in the
anterior raphe and with both Gai1 and Gaz in the
hypothalamus.
We have used agonist-induced [35S]GTPcS labelling
(Harrison & Traynor, 2003) in tissue sections (auto-
radiography) at the level of midbrain to visualize, in
a comparative way, the level of activation of the total
population of G proteins in DRN by two diﬀerent
agonists. As this procedure does not allow examin-
ation of coupling of GPCRs to individual Ga subunits,
we performed the recently developed G-protein anti-
body-capture assay coupled to Sepharose beads or to
scintillation proximity assay (SPA) detection in order
to study the activation patterns for the diﬀerent
G-protein subunits (Newman-Tancredi et al. 2002). In
agreement with previous data obtained in both re-
combinant systems (Bertin et al. 1992 ; Garnovskaya
et al. 1997 ; Raymond et al. 1993) and rat brain
(Mannoury la Cour, 2006), our results show that
native 5-HT1A receptors at DRN mainly couple to
Gai3 subunit, regardless of the agonist used. In con-
trast, coupling of these receptors to Gai2 or Gao sub-
units seems to depend on the agonist assayed.
Coupling of 5-HT1A receptors to Gai2 in vivo has been
reported to result in inhibition of AC and increase in
intracellular Ca2+ concentration (Albert et al. 1996 ;
Raymond et al. 1993). In this regard, it is noteworthy
that the agonist (+)8-OH-DPAT was not able to
couple to Gai2 subunits in DRN and did not inhibit
AC activity. 5-CT, a drug that similarly to 8-OH-
DPAT, behaves as a full agonist on all populations of
5-HT1A receptors, has also been reported to be unable
to induce both coupling of the receptor to the Gai2
subunit (Mannoury la Cour et al. 2001) and inhibition
of AC activity (Clarke et al. 1996) at the DRN level.
In contrast, our results demonstrate that buspirone, a
drug presenting a clear proﬁle of functional hetero-
geneity at 5-HT1A receptors, induces both coupling
of 5-HT1A receptor to Gao, Gai2 and Gai3 G-protein
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Fig. 2. Immunoprecipitation of G-protein subunit labelled
with [35S]GTPcS from 5-HT1A receptor/G-protein complexes
solubilized from dorsal raphe nucleus membranes after
incubation with 10 mM (+)8-OH-DPAT or 10 mM buspirone.
[35S]-labelled Ga subunits were immunoprecipitated then
bound onto protein GB-Sepharose beads, as described in the
Materials and methods section. Results are expressed as
percent of basal labelling with [35S]GTPcS. Each bar is the
mean¡S.E.M. of triplicate determinations in 6–8 independent
experiments. A signiﬁcant increase in [35S]GTPcS over the
basal value (100%) was observed for Gao (F=6.6, p<0.01),
Gai2 (F=6.0, p<0.05), and Gai3 (F=8.4, p<0.01), but not
for Gai1 (F=0.5, n.s.) or Gaz (F=0.7, n.s.). F : one-way
ANOVA; * p<0.05, ** p<0.01 vs. the basal binding and
+ p<0.05 vs. (+)8-OH-DPAT by Student–Newman–Keuls
post-hoc test.
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subunits and inhibition of signalling through cAMP
second-messenger cascade. From these results it is
tempting to suggest that 5-HT1A receptor-dependent
AC inhibition in DRNmight predominantly be related
to Gai2 subunit-mediated signalling. In contrast, Gai3
and Gao may be implicated in channel activity regu-
lation (reviewed in Raymond et al. 1999). In a similar
context, Newman-Tancredi and colleagues have re-
cently shown the existence of evidence for signal
transduction and functional selectivity at 5-HT1A re-
ceptors, comparing the responses induced by several
agonists (Newman-Tancredi et al. 2009).
5-HT7 receptors are also present at DRN and their
activation results in an increase of cAMP (Duncan &
Davis, 2005). Taking into account that 8-OH-DPAT
also binds with high aﬃnity to this receptor subtype,
it might be possible that their activation would mask
a 5-HT1A receptor-dependent cAMP modiﬁcation
induced by this agonist : this is not the case, as in the
presence of the selective 5-HT7 receptor antagonist
SB 269970, the lack of eﬀect of (+)8-OH-DPAT in rat
DRN was still observed.
The existence of heterogeneity in the activation
of transductional mechanisms following stimulation
of 5-HT1A receptors is well documented. On the other
hand, the preferential localization of these recep-
tors over cell bodies and dendrites of serotonergic
neurons at raphe nuclei has been widely demonstrated
(Sprouse & Aghajanian, 1987). In this regard, our re-
sults strongly suggest the existence, at the rat DRN
level, of drug-selective activation of speciﬁc G-protein
subunits, thus supporting the agonist-directed traf-
ﬁcking of receptor signalling theory (Kenakin, 1995).
Our results allow the re-interpretation of the diﬀerent
behaviour of buspirone at pre- and post-synaptic
5-HT1A receptors (full vs. partial agonism), although
the existence of a large receptor reserve among auto-
receptors in the raphe nuclei has been mentioned as a
possible reason, it could be suggested that the agonist-
dependent diﬀerential coupling to G-protein subunits
throughout the brain would better explain the diﬀer-
ences in eﬃcacy.
In contrast to our results in rat DRN, in hetero-
logous expression systems, such as CHO cells, both
full 5-HT1A receptor agonists (5-HT and 8-OH-DPAT)
and partial agonists (rauwolscine and ipsapirone)
have been reported to induce labelling of Gai2 and
Gai3 proteins with [
32P]AA-GTP, the level of isotopic
incorporation being lower for the latter drugs (Gettys
et al. 1994). These diﬀerences could be due to the fact
that, in heterologous expression systems, the environ-
mental conditions for the receptor and G-protein
subunits, including level of surface expression, are
completely diﬀerent from those occurring in native
F –9 –8 –7 –6 –5 –4
120
100
80
60
cA
M
P 
(%
 o
ve
r 
fo
rs
ko
lin
)
F –8 –7 –6 –5 –4
120
100
80
60
cA
M
P 
(%
 o
ve
r 
fo
rs
ko
lin
)
(+) 8-OH-DPAT (log M)
(+) 8-OH-DPAT + SB 269970 
(+) 8-OH-DPAT + WAY 100635
(+) 8-OH-DPAT
Buspirone (log M)
Buspirone
Buspirone + WAY 100635
F=136.9, p<0.001
(a) (b)
Fig. 3. Inhibition of forskolin-stimulated adenylyl cyclase (AC) activation by the 5-HT1A receptor agonist : (a) concentration-
dependent (+)8-OH-DPAT (10x9x10x4 M) modulation of forskolin-stimulated AC activity alone and in the presence of the
selective 5-HT1A receptor antagonist WAY 100635 (10
x5
M), or in the presence of the selective 5-HT7 receptor antagonist
SB 269970 (10x5 M). (b) concentration-dependent inhibition of forskolin-stimulated AC activity by buspirone (10x8x10x4 M)
alone and in the presence of the selective 5-HT1A receptor antagonist (10
x5
M). Percentages of inhibition were calculated
for each agonist concentration relative to forskolin-stimulated cAMP levels. Data are mean¡S.E.M. of six independent
experiments. F : sum of squares F test, buspirone vs. buspirone+WAY 100635.
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tissue. They also emphasize the interest in performing
these kind of studies in native tissue, when conclusions
for therapeutic activity of drugs are to be obtained.
Several functional results suggest a diﬀerential
activation of transductional mechanisms by 5-HT1A
receptor agonists. In this regard, 5-CT and 8-OH-
DPAT have been demonstrated to induce a marked
hypothermia and a ﬂattening of body posture. In con-
trast, no signiﬁcant reduction in core temperature or
induction of a marked ﬂattening of posture has been
observedwith buspirone (Higgins, 1988). Furthermore,
diﬀerences in the degree of activation of diverse trans-
ductional mechanisms have been implicated in the
origin of the regional diﬀerences in 5-HT1A receptor/
G-protein coupling observed (DRN vs. telencephalic
areas) following SSRI treatment in rats, as well as in
5-HTT-/- mice. (Castro et al. 2003 ; Fabre et al. 2000 ;
Hensler, 2002 ; Le Poul et al. 2000 ; Mannoury la Cour
et al. 2001).
Regarding the diversity of transductional responses
associated to 5-HT1A receptors, it must be taken into
account that a species-sensitive variation in the func-
tional coupling to AC has been observed in DRN
between rat and humans: in the rat, 5-HT1A receptor
activation by 8-OH-DPAT does not result in AC inhi-
bition (Clarke et al. 1996 ; Johnson et al. 1997, present
study), while activation by buspirone does modify
signalling of 5-HT1A receptors through cAMP (present
study). In contrast, inhibition of AC signalling through
activation of 5-HT1A receptors by both 8-OH-DPAT
(Palego et al. 1999, 2000) and buspirone (Marazziti et al.
2002) has been reported in humans. The molecular
basis of this species variation is not clear at the present
time.
In conclusion, our results demonstrate the existence
of agonist-directed traﬃcking for 5-HT1A receptor sig-
nalling in rat native brain tissue, helping to explain the
important diﬀerences in pharmacological eﬃcacy
found for some agonists, such as buspirone : these ﬁnd-
ings open new perspectives for the diﬀerential analysis
of pre- vs. post-synaptic 5-HT1A receptor-associated
responses. Moreover, this agonist-dependent diﬀer-
ential coupling to G-protein subunits can contribute
to the understanding of the diﬀerences found in the
adaptative changes of 5-HT1A receptor functionality
caused by chronic administration of 5-HT-acting
drugs, as it is the case with antidepressants.
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